香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容 概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就 因本公佈全部或任何部分內容而產生或因倚賴該等內容而引致之任何損 失承擔任何責任。 Kiu Hung International Holdings Limited 僑 雄 國 際 控 股 有 限 公 司 （於開曼群島註冊成立並於百慕達存續之有限公司） （股份代號：00381） 二 零 二 三 年 中 期 業 績 公 佈 僑雄國際控股有限公司（「本公司」）董事（「董事」）會（「董事會」）欣然公佈本 公司及其附屬公司與聯營公司（「本集團」）截至二零二三年六月三十日止 六個月之未經審核簡明綜合中期業績。 簡明綜合損益表 截至六月三十日止六個月 二零二三年 二零二二年 （未經審核） （未經審核） 附註 千港元 千港元 營業額 4 152,924 193,988 銷售成本 (81,664) (133,365) 毛利 71,260 60,623 ...

Financial Performance - The company reported a revenue of approximately HKD 420,904,000 for the fiscal year ending December 31, 2022, representing a 30.02% increase from HKD 323,718,000 in 2021[4] - Gross profit for the year was HKD 157,020,000, a significant increase of 70.82% compared to HKD 91,922,000 in the previous year[4] - The loss attributable to shareholders decreased to HKD 59,521,000, down 73.75% from HKD 226,754,000 in 2021[4] - The basic loss per share improved to HKD 0.1174, a reduction of 89.83% from HKD 1.1548 in the prior year[4] - The group reported a loss of approximately HKD 5,800,000 for the year, compared to a loss of HKD 7,500,000 in the previous year[17] - The net loss for the year was HKD 38,501,000, significantly improved from a loss of HKD 220,496,000 in 2021[162] - The company reported a loss of HKD 59,521,000 for the year ended December 31, 2022, compared to a loss of HKD 226,754,000 in the previous year, indicating an improvement in financial performance[167] Revenue Sources - Revenue from the Chinese herbal medicine business was approximately HKD 127,900,000, an increase from HKD 59,400,000 in the previous year[24] - Revenue from North America was approximately HKD 292,000,000, up from HKD 263,000,000, accounting for 69.3% of total revenue[25] - The herbal medicine segment contributed a profit of HKD 36,800,000, enhancing the overall financial performance of the group[7] Assets and Equity - The total assets of the company decreased by 8.00% to HKD 879,939,000 from HKD 956,439,000 in the previous year[4] - The total equity increased by 34.31% to HKD 285,008,000 compared to HKD 212,194,000 in 2021[4] - The company's net asset value increased to HKD 285,008,000 in 2022 from HKD 212,194,000 in 2021[165] Dividends - The company has decided not to declare any final dividend for the year, consistent with the previous year[7] - The company did not recommend any final dividend for the year ended December 31, 2022[39] - The company has adopted a semi-annual dividend policy, aiming to maintain stable returns through gradual increases and special dividends[97] Expenses and Costs - The group's total administrative expenses increased by approximately 0.4% to about HKD 78,800,000[27] - Financial costs for the year were approximately HKD 46,800,000, an increase of about 6.1% from HKD 44,100,000 in the previous year[28] - Total costs related to retirement benefit plans amounted to approximately HKD 2.512 million for the year, an increase from approximately HKD 2.405 million in 2021[67] Capital Structure and Financing - The group plans to acquire 49% of Jiangxi Jiuai Food Co., Ltd. for HKD 45,750,000, with part of the payment in shares and convertible bonds[36] - The company is actively considering fundraising activities to raise new capital, including rights issues, public offerings, placements of new shares, and issuing convertible bonds[127] - The group has agreed with certain noteholders and creditors not to demand repayment of approximately HKD 72,900,000 and HKD 6,176,000 due before March 19, 2024[175] Governance and Compliance - The company’s board of directors presented the audited consolidated financial statements for the year ended December 31, 2022[52] - The company is committed to achieving excellence in corporate governance and has complied with applicable codes[103] - The board consists of three executive directors and three independent non-executive directors, ensuring independence and compliance with listing rules[106] - The audit committee held two meetings in 2022, with all members being independent non-executive directors[116] Internal Controls and Risk Management - The board has reviewed the risk management and internal control systems for the year ended December 31, 2022, and deemed them effective[129] - The group has engaged an independent consultant to review its internal control systems, covering financial, operational, and compliance controls[128] - The group has adopted a risk management framework that includes identifying significant risks, assessing their impact, and monitoring the effectiveness of management measures[130] Employee and Community Engagement - The company employed a total of 399 employees as of December 31, 2022, an increase from 386 employees in the previous year[45] - The company made charitable donations totaling approximately HKD 28,000 during the year, a significant decrease from HKD 181,000 in 2021[65] Environmental Responsibility - The company emphasizes environmental responsibility, implementing measures to reduce carbon footprint and energy consumption[92] - The company has implemented various paper-saving measures to minimize waste and promote recycling[95] Future Outlook - The company is continuously reviewing its existing business and exploring other profitable investment opportunities to diversify its business and revenue base[41] - The group is considering various strategies for market expansion and new product development, although specific details were not disclosed in the provided content[174]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容 概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不會 就因本公佈全部或任何部分內容而產生或因依賴該等內容而引致之任何 損失承擔任何責任。 Kiu Hung International Holdings Limited 僑 雄 國 際 控 股 有 限 公 司 （於開曼群島註冊成立並於百慕達存續之有限公司） （股份代號：00381） 截 至 二 零 二 二 年 十 二 月 三 十 一 日 止 年 度 全 年 業 績 公 佈 ...

Financial Performance - The group recorded a revenue of approximately HKD 193.9 million for the six months ended June 30, 2022, representing an increase of about 125% compared to HKD 86.3 million in the same period last year[5]. - The loss attributable to equity holders of the company was approximately HKD 23.5 million, a decrease from HKD 46.1 million in the previous year, primarily due to increased revenue from toys, gifts, and traditional Chinese medicine[5]. - Revenue for the six months ended June 30, 2022, was HKD 193,988,000, a significant increase from HKD 86,334,000 in the same period of 2021, representing a growth of 124.5%[37]. - Gross profit for the same period was HKD 60,623,000, compared to HKD 23,970,000 in 2021, indicating a gross margin improvement[37]. - The net loss for the six months ended June 30, 2022, was HKD 13,983,000, a reduction from a net loss of HKD 44,673,000 in 2021, showing an improvement of 68.7%[39]. - The reported total profit for the six months ended June 30, 2022, was HKD 19,386,000, compared to a loss of HKD 959,000 for the same period in 2021[64]. - The company incurred a loss of approximately HKD 13,983,000 for the six months ended June 30, 2022, raising concerns about its ability to continue as a going concern[53]. Revenue Segments - The toys and gifts segment generated revenue of approximately HKD 137.1 million, with a gross profit margin of 31.3%, up from 27.8% in the previous year, attributed to reduced material costs[7]. - The revenue from the traditional Chinese medicine business was approximately HKD 56.9 million, significantly up from HKD 7.8 million in the previous year[17]. - Total revenue from external customers for the toys and gifts segment was HKD 137,112,000, representing a significant increase from HKD 78,504,000 in the same period of 2021[61]. Cash and Liquidity - The group’s cash and bank balances were approximately HKD 75.4 million as of June 30, 2022, down from HKD 201.1 million as of December 31, 2021[19]. - The company reported a net cash outflow from operating activities of HKD 138,649,000 for the six months ended June 30, 2022, compared to HKD 28,788,000 for the same period in 2021, indicating a significant increase in cash burn[50]. - The company’s current liabilities exceeded its current assets by approximately HKD 253,174,000 as of June 30, 2022, indicating liquidity challenges[53]. - The company is actively negotiating with financial institutions to secure additional financing and extend repayment terms with creditors[55]. - The company is considering fundraising activities, including rights issues and public offerings, to raise new capital[55]. Assets and Liabilities - The company's total assets decreased to HKD 903,812,000 as of June 30, 2022, down from HKD 956,439,000 at the end of 2021[42]. - The total liabilities decreased to HKD 636,081,000 from HKD 658,843,000, showing a reduction of 3.4%[44]. - The company's equity attributable to shareholders decreased to HKD 94,149,000 from HKD 135,127,000, a decline of 30.4%[44]. - Inventory levels increased significantly to HKD 101,858,000 from HKD 35,355,000 in the previous year, indicating a rise of 187.5%[42]. - The net trade receivables increased to HKD 73,443,000 as of June 30, 2022, compared to HKD 26,963,000 at the end of 2021, reflecting a growth of approximately 172.5%[73]. Capital Structure and Financing - The group’s borrowings were approximately HKD 120.5 million as of June 30, 2022, compared to HKD 118.5 million as of December 31, 2021[19]. - The capital debt ratio as of June 30, 2022, was 264.8%, up from 180.9% as of December 31, 2021[20]. - The company completed a capital restructuring on June 27, 2022, consolidating every five existing shares into one new share with a par value of HKD 0.05[79]. - The company received valid acceptances for the issuance of 15,898,476 new shares under a rights issue on July 22, 2022, with 675,217,317 shares successfully placed at HKD 0.205 each[90]. - The total amount raised from the rights issue is approximately HKD 141,680,000, with a net amount of approximately HKD 139,810,000 after deducting all related expenses[91]. Operational Challenges - The group is evaluating the impact of the COVID-19 pandemic on its operations and financials, particularly regarding the delayed construction of high-end hotel casinos and residential properties[11]. - The company has implemented strict credit monitoring to minimize credit risk, with overdue balances reviewed regularly by senior management[73]. - The company has no significant legal claims or disputes pending as of the report date[87][88]. Dividends and Share Options - The group has decided not to declare any interim dividend for the period, consistent with the previous year[5]. - The company has no unexercised share options as of June 30, 2022, and the share option plan approved in May 2013 will expire on May 30, 2023[24].

目 錄 | 公司資料 | 2 | | --- | --- | | 財務概要 | 3 | | 主席報告書 | 4 | | 管理層討論及分析 | 6 | | 董事及高層管理人員簡介 | 13 | | 董事會報告 | 15 | | 企業管治報告 | 23 | | 獨立核數師報告 | 30 | | 經審核綜合財務報表 | | | 綜合損益表 | 37 | | 綜合損益及其他全面收入表 | 38 | | 綜合財務狀況表 | 39 | | 綜合權益變動表 | 41 | | 綜合現金流量表 | 42 | | 綜合財務報表附註 | 44 | | 五年財務概要 | 148 | 公司 資料 執行董事： 張啟軍先生 （主席） 劉明卿先生 黎綺雯女士 獨立非執行董事： 王小寧先生 鄭皓安先生 江俊榮先生 黎子彥先生 陳雨鑫女士 註冊辦事處 Zuill Corporate Services (Bermuda) Limited Continental Buildings 25 Church Street Hamilton HM 12 Bermuda 總辦事處及主要營業地點 香港 灣仔 駱克道315–321號 駱基中心 20樓E室 百慕達 ...

| | | | 公 | 司 | 資 | 料 | | | | | | | | | 2 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 管 | 理 | 層 | 討 | 論 | 及 | 分 | 析 | | | | | 3 | | 企 | 業 | 管 | 治 | 及 | 其 | 他 | 資 | 料 | | | | 7 | | 簡 | 明 | 綜 | 合 | 損 | 益 | 表 | | | | | | 9 | | 簡 | 明 | 綜 | 合 | 全 | 面 | 收 | 入 | 報 | 表 | | | 1 0 | | 簡 | 明 | 綜 | 合 | 財 | 務 | 狀 | 況 | 表 | | | | 1 1 | | 簡 | 明 | 綜 | 合 | 權 | 益 | 變 | 動 | 表 | | | | 1 3 | | 簡 | 明 | 綜 | 合 | 現 | 金 | 流 | 量 | 表 | | | | 1 4 | | 簡 | 明 | 綜 | 合 | 中 | 期 | 財 | 務 | 報 | 表 | 附 | 註 ...

於開曼群島註冊成立之有限公司 股份代號 邁步向前 Leading the Way Towards | | | | 公司資料 | 2 | | --- | --- | | 財務概要 | 3 | | 主席報告書 | 4 | | 管理層討論及分析 | 6 | | 董事及高層管理人員簡介 | 13 | | 董事會報告 | 15 | | 企業管治報告 | 23 | | 獨立核數師報告 | 30 | | 經審核綜合財務報表 | | | 綜合損益表 | 36 | | 綜合損益及其他全面收入表 | 37 | | 綜合財務狀況表 | 38 | | 綜合權益變動表 | 40 | | 綜合現金流量表 | 41 | | 綜合財務報表附註 | 43 | | 五年財務概要 | 136 | 公司 資料 執行董事： 張啟軍先生 （主席） 陳劍先生 劉明卿先生 獨立非執行董事： 王小寧先生 鄭皓安先生 江俊榮先生 黎子彥先生 陳雨鑫女士 註冊辦事處 Zuill Corporate Services (Bermuda) Limited Continental Buildings 25 Church Street Hamilton HM 12 Be ...

| | | | 公 | 司 | 資 | 料 | | | | | | | | | 2 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 管 | 理 | 層 | 討 | 論 | 及 | 分 | 析 | | | | | 3 | | 企 | 業 | 管 | 治 | 及 | 其 | 他 | 資 | 料 | | | | 8 | | 簡 | 明 | 綜 | 合 | 損 | 益 | 表 | | | | | | 1 0 | | 簡 | 明 | 綜 | 合 | 全 | 面 | 收 | 入 | 報 | 表 | | | 1 1 | | 簡 | 明 | 綜 | 合 | 財 | 務 | 狀 | 況 | 表 | | | | 1 2 | | 簡 | 明 | 綜 | 合 | 權 | 益 | 變 | 動 | 表 | | | | 1 4 | | 簡 | 明 | 綜 | 合 | 現 | 金 | 流 | 量 | 表 | | | | 1 5 | | 簡 | 明 | 綜 | 合 | 中 | 期 | 財 | 務 | 報 | 表 | 附 | ...

於開曼群島註冊成立之有限公司 股份代號 邁步向前 Leading the Way Towards 創建未來 ANNUAL REPORT 2 0 1 9 FUTURE A BRIGHT 年 報 2 0 1 9 Kiu Hung International Holdings Limited 僑雄國際控股有限公司 ANNUAL REPO RT 2019 年報 目 錄 | 公司資料 | 2 | | --- | --- | | 財務概要 | 3 | | 主席報告書 | 4 | | 管理層討論及分析 | 5 | | 董事及高層管理人員簡介 | 13 | | 董事會報告 | 15 | | 企業管治報告 | 23 | | 獨立核數師報告 | 30 | | 經審核綜合財務報表 | | | 綜合損益表 | 37 | | 綜合損益及其他全面收入表 | 38 | | 綜合財務狀況表 | 39 | | 綜合權益變動表 | 41 | | 綜合現金流量表 | 42 | | 綜合財務報表附註 | 44 | | 五年財務概要 | 136 | 公司 資料 執行董事： 張啟軍先生 （主席） 陳劍先生 劉明卿先生 獨立非執行董事： 王小寧先生 鄭皓 ...

目 錄 | 公 | 司 | 資 | 料 | | | | | | | | 2 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 管 | 理 | 層 | 討 | 論 | 及 | 分 | 析 | | | | 3 | | 企 | 業 | 管 | 治 | 及 | 其 | 他 | 資 | 料 | | | 8 | | 簡 | 明 | 綜 | 合 | 損 | 益 | 表 | | | | | 1 3 | | 簡 | 明 | 綜 | 合 | 全 | 面 | 收 | 入 | 報 表 | | | 1 4 | | 簡 | 明 | 綜 | 合 | 財 | 務 | 狀 | 況 | 表 | | | 1 5 | | 簡 | 明 | 綜 | 合 | 權 | 益 | 變 | 動 | 表 | | | 1 7 | | 簡 | 明 | 綜 | 合 | 現 | 金 | 流 | 量 | 表 | | | 1 8 | | 簡 | 明 | 綜 | 合 | 中 | 期 | 財 | 務 | 報 表 | 附 | 註 | 1 9 | 公司 資料 執行董事 張啟軍先生 ...